• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应激诱导CHO细胞中单克隆抗体产量增加。

Stress-induced increase of monoclonal antibody production in CHO cells.

作者信息

Schellenberg Jana, Nagraik Tamanna, Wohlenberg Ole Jacob, Ruhl Sebastian, Bahnemann Janina, Scheper Thomas, Solle Dörte

机构信息

Institut für Technische Chemie Leibniz Universität Hannover Hannover Germany.

Field Application Specialist - Cell Culture Technologies Sartorius Stedim Biotech GmbH Göttingen Germany.

出版信息

Eng Life Sci. 2022 Feb 24;22(5):427-436. doi: 10.1002/elsc.202100062. eCollection 2022 May.

DOI:10.1002/elsc.202100062
PMID:35573136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9077828/
Abstract

Monoclonal antibodies (mAbs) are of great interest to the biopharmaceutical industry due to their widely used application as human therapeutic and diagnostic agents. As such, mAb require to exhibit human-like glycolization patterns. Therefore, recombinant Chinese hamster ovary (CHO) cells are the favored production organisms; many relevant biopharmaceuticals are already produced by this cell type. To optimize the mAb yield in CHO DG44 cells a corelation between stress-induced cell size expansion and increased specific productivity was investigated. CO and macronutrient supply of the cells during a 12-day fed-batch cultivation process were tested as stress factors. Shake flasks (500 mL) and a small-scale bioreactor system (15 mL) were used for the cultivation experiments and compared in terms of their effect on cell diameter, integral viable cell concentration (IVCC), and cell-specific productivity. The achieved stress-induced increase in cell-specific productivity of up to 94.94.9%-134.4% correlates to a cell diameter shift of up to 7.34 μm. The highest final product titer of 4 g/L was reached by glucose oversupply during the batch phase of the process.

摘要

单克隆抗体(mAb)作为人类治疗和诊断试剂被广泛应用,因此受到生物制药行业的极大关注。正因如此,单克隆抗体需要呈现出类似人类的糖基化模式。所以,重组中国仓鼠卵巢(CHO)细胞是首选的生产生物体;许多相关生物制药已经由这种细胞类型生产。为了优化CHO DG44细胞中单克隆抗体的产量,研究了应激诱导的细胞大小扩张与特定生产力提高之间的相关性。在为期12天的补料分批培养过程中,测试了细胞的CO和常量营养素供应作为应激因素。使用摇瓶(500 mL)和小型生物反应器系统(15 mL)进行培养实验,并比较它们对细胞直径、活细胞总数(IVCC)和细胞比生产力的影响。所实现的应激诱导细胞比生产力提高高达94.9%-134.4%,这与细胞直径最多7.34μm的变化相关。在该过程的分批阶段通过过量供应葡萄糖达到了最高终产物滴度4 g/L。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/131c7f535779/ELSC-22-427-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/eb8e6efb5009/ELSC-22-427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/242f6155669c/ELSC-22-427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/8342a46d774e/ELSC-22-427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/cc477a031bea/ELSC-22-427-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/131c7f535779/ELSC-22-427-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/eb8e6efb5009/ELSC-22-427-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/242f6155669c/ELSC-22-427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/8342a46d774e/ELSC-22-427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/cc477a031bea/ELSC-22-427-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e5/9077828/131c7f535779/ELSC-22-427-g004.jpg

相似文献

1
Stress-induced increase of monoclonal antibody production in CHO cells.应激诱导CHO细胞中单克隆抗体产量增加。
Eng Life Sci. 2022 Feb 24;22(5):427-436. doi: 10.1002/elsc.202100062. eCollection 2022 May.
2
QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.由质量源于设计(QbD)引导的帕博利珠单抗生物类似药候选药物PSG-024的药物研发,已达到与可瑞达®(Keytruda®)具有可比性这一行业会议的主要要求。
Eur J Pharm Sci. 2022 Jun 1;173:106171. doi: 10.1016/j.ejps.2022.106171. Epub 2022 Apr 1.
3
Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.利用人工染色体表达技术在中华仓鼠卵巢细胞中表达 IgG1 的补料分批生物反应器性能和细胞系稳定性评估。
Biotechnol Prog. 2011 Jan-Feb;27(1):201-8. doi: 10.1002/btpr.505. Epub 2010 Nov 23.
4
Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.在利用中国仓鼠卵巢细胞生产单克隆抗体过程中,使用可诱导的抗凋亡基因E1B-19K和Aven增强细胞培养性能。
Biotechnol Bioeng. 2007 Jul 1;97(4):877-92. doi: 10.1002/bit.21222.
5
A comprehensive comparison of mixing and mass transfer in shake flasks and their relationship with MAb productivity of CHO cells.摇瓶中的混合与传质的综合比较及其与 CHO 细胞单抗生产能力的关系。
Bioprocess Biosyst Eng. 2022 Jun;45(6):1033-1045. doi: 10.1007/s00449-022-02722-y. Epub 2022 Mar 26.
6
Low-concentration staurosporine improves recombinant antibody productivity in Chinese hamster ovary cells without inducing cell death.低浓度星形孢菌素在不诱导细胞死亡的情况下提高中国仓鼠卵巢细胞中重组抗体的产量。
J Biosci Bioeng. 2020 Nov;130(5):525-532. doi: 10.1016/j.jbiosc.2020.07.005. Epub 2020 Aug 12.
7
Process development for an inducible rituximab-expressing Chinese hamster ovary cell line.诱导型表达利妥昔单抗的中国仓鼠卵巢细胞系的工艺开发。
Biotechnol Prog. 2019 Jan;35(1):e2742. doi: 10.1002/btpr.2742. Epub 2018 Nov 30.
8
Using simple models to describe the kinetics of growth, glucose consumption, and monoclonal antibody formation in naive and infliximab producer CHO cells.使用简单模型描述原始CHO细胞和英夫利昔单抗生产型CHO细胞的生长动力学、葡萄糖消耗及单克隆抗体形成。
Cytotechnology. 2016 Aug;68(4):1287-300. doi: 10.1007/s10616-015-9889-2. Epub 2015 Jun 20.
9
Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.分批补料CHO细胞培养中的氨基酸和葡萄糖代谢会影响抗体的产生和糖基化。
Biotechnol Bioeng. 2015 Mar;112(3):521-35. doi: 10.1002/bit.25450. Epub 2014 Oct 10.
10
Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.CHO细胞中热休克蛋白27的过表达可调节凋亡途径并延迟半胱天冬酶的激活,从而提高分批补料生物反应器中重组单克隆抗体的产量。
Biotechnol J. 2015 May;10(5):790-800. doi: 10.1002/biot.201400764. Epub 2015 Apr 8.

引用本文的文献

1
Antibody Aggregate Removal by Multimodal Chromatography.通过多模式色谱法去除抗体聚集体
Molecules. 2025 May 29;30(11):2363. doi: 10.3390/molecules30112363.
2
Improving outcomes in intensified processing via optimization of the cell line development workflow.通过优化细胞系开发工作流程来改善强化处理的结果。
Biotechnol Prog. 2025 May-Jun;41(3):e70003. doi: 10.1002/btpr.70003. Epub 2025 Feb 19.
3
Machine Learning-Powered Optimization of a CHO Cell Cultivation Process.基于机器学习的CHO细胞培养过程优化

本文引用的文献

1
Dynamic metabolic flux analysis using B-splines to study the effects of temperature shift on CHO cell metabolism.使用B样条曲线进行动态代谢通量分析以研究温度变化对CHO细胞代谢的影响。
Metab Eng Commun. 2015 Jun 19;2:46-57. doi: 10.1016/j.meteno.2015.06.001. eCollection 2015 Dec.
2
Monitoring cell productivity for the production of recombinant proteins by flow cytometry: An effective application using the cold capture assay.通过流式细胞术监测重组蛋白生产中的细胞生产力:使用冷捕获测定法的有效应用。
Eng Life Sci. 2021 Jan 6;21(5):288-293. doi: 10.1002/elsc.202000049. eCollection 2021 May.
3
Implementation of QbD strategies in the inoculum expansion of a mAb production process.
Biotechnol Bioeng. 2025 May;122(5):1153-1164. doi: 10.1002/bit.28943. Epub 2025 Jan 31.
4
Optimization of the intron sequences combined with the CMV promoter increases recombinant protein expression in CHO cells.内含子序列与巨细胞病毒(CMV)启动子相结合的优化可提高重组蛋白在CHO细胞中的表达。
Sci Rep. 2025 Jan 29;15(1):3732. doi: 10.1038/s41598-025-87941-5.
5
Characterization of the Ubiquitin-Modified Proteome of Recombinant Chinese Hamster Ovary Cells in Response to Endoplasmic Reticulum Stress.重组中国仓鼠卵巢细胞内质网应激反应中泛素修饰蛋白质组的表征
Biotechnol J. 2024 Nov;19(11):e202400413. doi: 10.1002/biot.202400413.
6
Establishment of a Perfusion Process with Antibody-Producing CHO Cells Using a 3D-Printed Microfluidic Spiral Separator with Web-Based Flow Control.使用具有基于网络流量控制的3D打印微流控螺旋分离器建立产生抗体的CHO细胞灌注过程。
Bioengineering (Basel). 2023 May 28;10(6):656. doi: 10.3390/bioengineering10060656.
7
Progress in fed-batch culture for recombinant protein production in CHO cells.补料分批培养 CHO 细胞生产重组蛋白的进展。
Appl Microbiol Biotechnol. 2023 Feb;107(4):1063-1075. doi: 10.1007/s00253-022-12342-x. Epub 2023 Jan 17.
质量源于设计(QbD)策略在单克隆抗体生产过程种子扩增中的实施
Eng Life Sci. 2020 Dec 3;21(3-4):196-207. doi: 10.1002/elsc.202000056. eCollection 2021 Mar.
4
A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.一种将分批补料平台工艺转换为半灌注模式的方案:与摇瓶相比,自动化小型生物反应器作为缩小规模模型的优势。
Biotechnol Prog. 2019 Mar;35(2):e2757. doi: 10.1002/btpr.2757. Epub 2018 Dec 19.
5
Perfusion mammalian cell culture for recombinant protein manufacturing - A critical review.哺乳动物细胞灌流培养用于重组蛋白生产——综述
Biotechnol Adv. 2018 Jul-Aug;36(4):1328-1340. doi: 10.1016/j.biotechadv.2018.04.011. Epub 2018 May 5.
6
Metabolic characterization of a CHO cell size increase phase in fed-batch cultures.补料分批培养中 CHO 细胞生长阶段的代谢特征。
Appl Microbiol Biotechnol. 2017 Nov;101(22):8101-8113. doi: 10.1007/s00253-017-8531-y. Epub 2017 Sep 26.
7
Impact of Pluronic F68 on hollow fiber filter-based perfusion culture performance.聚醚砜 F68 对基于中空纤维过滤器的灌流培养性能的影响。
Bioprocess Biosyst Eng. 2017 Sep;40(9):1317-1326. doi: 10.1007/s00449-017-1790-2. Epub 2017 Jun 2.
8
High-density mammalian cell cultures in stirred-tank bioreactor without external pH control.在无外部pH值控制的搅拌罐式生物反应器中进行的高密度哺乳动物细胞培养。
J Biotechnol. 2016 Aug 10;231:149-159. doi: 10.1016/j.jbiotec.2016.06.019. Epub 2016 Jun 16.
9
Advances in recombinant antibody manufacturing.重组抗体制造的进展。
Appl Microbiol Biotechnol. 2016 Apr;100(8):3451-61. doi: 10.1007/s00253-016-7388-9. Epub 2016 Mar 3.
10
Heterologous protein production using euchromatin-containing expression vectors in mammalian cells.在哺乳动物细胞中使用含常染色质的表达载体生产异源蛋白。
Nucleic Acids Res. 2015 Sep 18;43(16):e102. doi: 10.1093/nar/gkv475. Epub 2015 May 14.